Evercore ISI Group Maintains Outperform on TransMedics Group, Lowers Price Target to $90
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $100 to $90.
Evercore ISI Group analyst Daniel Markowitz maintains TransMedics Group (NASDAQ:TMDX) with a Outperform and lowers the price target from $100 to $90.